Clincosm LogoSign in Get a demo

lymphangioleiomyomatosis (lam)

Showing 1 - 3 of 3
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphangioleiomyomatosis (LAM) Trial in Boston (Celecoxib)

Completed
Has Results
  • Lymphangioleiomyomatosis (LAM)
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jan 18, 2022

Lymphangioleiomyomatosis (LAM) Trial in Nashville (Glutamine)

Completed
  • Lymphangioleiomyomatosis (LAM)
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Aug 10, 2021

Tuberous Sclerosis Complex (TSC), Lymphangioleiomyomatosis (LAM) Trial in Worldwide (Everolimus (RAD001), Everolimus Placebo)

Completed
Has Results
  • Tuberous Sclerosis Complex (TSC)
  • Lymphangioleiomyomatosis (LAM)
  • Everolimus (RAD001)
  • Everolimus Placebo
  • Birmingham, Alabama
  • +24 more
Jan 3, 2017